Publications
148
Citations
2,340
Est. group size
—
Recurring co-author estimate
Active years
47
Publishing since 1980
Skyler B. Johnson conducts medical research focused on prostate cancer treatment, particularly radiation-based therapies and prognostic tools for advanced disease. A second major thread of the work examines how cancer patients encounter and communicate with clinicians about online health information and treatment misinformation. Together, the research spans both clinical oncology trials and the study of how patients navigate health information.
Publication activity has been steady over the past decade, averaging around 10-14 papers per year with no clear increase or decrease.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Blood cancer caregivers’ communication with clinicians about online cancer information
Palliative & Supportive Care · 2026
- Navigating Disagreements on Health Information: How Patients With Cancer Perceive Health Care Providers' Approaches to Discussing Patient-Identified Information
JCO Oncology Practice · 2025
- When Limited Clinical Time With Patients Meets Unlimited Online Information
JMIR Cancer · 2025
- Industry Sponsorship and Disease Site Focus in Therapeutic Radiopharmaceutical Clinical Trials Over the Past Decade
International Journal of Radiation Oncology*Biology*Physics · 2025
- A Phase 2 Trial of Radium223 and Stereotactic Ablative Radiation Therapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR Study
International Journal of Radiation Oncology*Biology*Physics · 2025
- Using AI to identify optimal clinical, genomic, and radiographic prognostic features and novel risk classifiers compared to routinely available risk classifiers.
Journal of Clinical Oncology · 2025
- Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer
Clinical Proteomics · 2025
- Plasma proteome-based integrative prognostic nomogram in metastatic castrate-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology · 2025
- Phase II trial of image-guided oligometastatectomy and radiation therapy in recurrent prostate cancer (SOAR).
Journal of Clinical Oncology · 2025
- Paging Dr. Google: Characterizing Direct-to-Consumer Digital Advertisements From Oncology Treatment Centers
Cureus · 2025
- PD13-02 PHASE II TRIAL OF IMAGE-GUIDED OLIGOMETASTATECTOMY AND RADIATION THERAPY IN RECURRENT PROSTATE CANCER (SOAR)
The Journal of Urology · 2025
- Plasma proteome molecular sequencing–based prognostic nomogram in metastatic castrate-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology · 2025
- Frequency of patients' communication with their oncologists about cancer treatment misinformation
Patient Education and Counseling · 2025
- Assessing Cancer Patients’ Exposure to Treatment Misinformation
Journal of Cancer Education · 2025
- 62P Prognostic plasma proteome-based nomogram in metastatic castrate-resistant prostate cancer (mCRPC)
ESMO Open · 2025
- International Journal of Radiation Oncology*Biology*Physics×24
- Journal of Clinical Oncology×20
- JNCI Journal of the National Cancer Institute×3
- JCO Oncology Practice×3
- Practical Radiation Oncology×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile